Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Sogroya® (somapacitan-beco) – New drug approval
August 28, 2020 - Novo Nordisk announced the FDA approval of Sogroya (somapacitan-beco), for replacement of endogenous growth hormone in adults with growth hormone deficiency (GHD).
